MDT_logo.png
Medtronic Receives CE Mark for InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI Leads
January 13, 2020 09:00 ET | Medtronic plc
Full-Body MRI-Conditional InterStim II and InterStim Micro Systems Offer Lifestyle-Friendly Choices in Sacral Neuromodulation Therapy to Europeans Suffering from Incontinence DUBLIN, Jan. 13, 2020...
Percept™ PC Neurostimulator with BrainSense™ Technology
Medtronic Receives CE Mark Approval for the Percept™ PC Neurostimulator DBS System with BrainSense™ Technology
January 09, 2020 08:00 ET | Medtronic plc
This Next-Generation DBS Technology Allows Physicians to Review Patient-Specific Brain Signals, Enabling More Personalized, Data-Driven Neurostimulation Treatment for Patients DUBLIN, Jan. 09,...
MDT_logo.png
Medtronic Acquires Stimgenics, Pioneer of DTM™, a Novel Spinal Cord Stimulation Therapy
January 08, 2020 17:19 ET | Medtronic plc
Randomized Control Trial Results to be Presented at NANS Jan. 23-26 in Las Vegas; New, Proprietary Differential Target Multiplexed (DTM) Therapy Available on Medtronic Intellis Spinal Cord Stimulation...
MDT_logo.png
Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference
January 06, 2020 14:00 ET | Medtronic plc
DUBLIN, Jan. 06, 2020 (GLOBE NEWSWIRE) --  Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 38th Annual J.P. Morgan Healthcare Conference...
MDT_logo.png
Medtronic Expands Surgical Synergy(SM) with FDA Clearance of the Stealth Autoguide™ System for Cranial Procedures
December 18, 2019 07:00 ET | Medtronic plc
Robotic Trajectory Guidance Platform Integrates Multiple Enabling Technologies to Support Complex Cranial Procedures DUBLIN, Dec. 18, 2019 (GLOBE NEWSWIRE) --  Medtronic plc (NYSE:MDT) announced...
MDT_logo.png
Medtronic Acquires Klue
December 17, 2019 09:00 ET | Medtronic plc
Acquisition Strengthens Development of Personalized Closed Loop Technology for Diabetes Management DUBLIN, Dec. 17, 2019 (GLOBE NEWSWIRE) --  Medtronic plc (NYSE:MDT), the global leader in...
Medtronic and ChristianaCare
Medtronic and ChristianaCare Collaborate to Improve Patient Outcomes and Reduce Cost of Care in Delaware
December 16, 2019 08:00 ET | Medtronic plc
Value-Based Healthcare Collaboration Designed to Help ChristianaCare Apply Right Therapies to Patients Who May Benefit Most DUBLIN and NEW CASTLE, Del., Dec. 16, 2019 (GLOBE NEWSWIRE)...
MDT_logo.png
Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2020
December 06, 2019 06:45 ET | Medtronic plc
DUBLIN, Dec. 06, 2019 (GLOBE NEWSWIRE) -- The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2020 third quarter cash dividend of $0.54 per ordinary share,...
MDT_logo.png
Medtronic Drug-Coated Balloon Receives U.S. FDA Approval to Treat Arteriovenous Fistula Lesions
November 21, 2019 11:05 ET | Medtronic plc
Clinical Data Demonstrates IN.PACT™ AV DCB Is Safe, Reduces Reinterventions, and Maintains Access for End-Stage Renal Disease Patients Undergoing Dialysis DUBLIN, Nov. 21, 2019 (GLOBE NEWSWIRE)...
MDT_logo.png
Medtronic Reports Second Quarter Financial Results
November 19, 2019 06:45 ET | Medtronic plc
 Revenue of $7.7 Billion Increased 3.0% Reported and 4.1% Organic GAAP Diluted EPS of $1.01; Non-GAAP Diluted EPS of $1.31 Cash Flow from Operations of $1.9 Billion Grew 61%; Free Cash Flow of $1.6...